Documents to download

The Mesothelioma (Amendment) Bill [HL] is a private member’s bill introduced by Lord Alton of Liverpool (Crossbench). The Bill received its first reading in the House of Lords on 2 June 2015 and is due to receive its second reading on 20 November 2015. The Bill seeks to amend the Mesothelioma Act 2014 to ensure that the levy paid by insurance companies, introduced by the 2014 Act, is also used to fund research into mesothelioma.

  • Section 13(1) of the Mesothelioma Act 2014 instructs the Secretary of State to make regulations requiring active insurers to pay a levy with a view to meeting the costs of the Diffuse Mesothelioma Payment Scheme. Clause 1(2) of the proposed Mesothelioma (Amendment) Bill would amend the Mesothelioma Act 2014 to require the regulations to specify that the levy should include a research supplement.
  • Clause 1(2) includes details of the level of the research supplement. It would require the research supplement to be expressed as a percentage of the levy and not to exceed 1 percent.
  • Clause 1(2) provides details of the uses and functioning of the research supplement. Regulations would include details of the provision of financial assistance for research into mesothelioma to be applied by way of grants or other financial assistance and require the scheme administrator to make arrangements for the application of the research supplement.
  • Clause 1(2) requires the Secretary of State to consult with insurers, medical charities and research foundations, and other persons or bodies who the Secretary of State thinks might be interested, prior to making any regulations regarding the research supplement.

The Bill is identical to the Mesothelioma (Amendment) Bill 2014–15, a private member’s bill introduced by Lord Alton of Liverpool on 17 July 2014; the Bill did not received a second reading.


Documents to download

Related posts

  • The Legislative Reform (Renewal of Radio Licences) Order 2020 is a specific kind of statutory instrument called a legislative reform order (LRO). Such orders are designed to reduce certain burdens caused by legislation. These particular orders would extend analogue radio licences due to expire from 2022 for a further ten-year period on the condition that they also provide a service on an appropriate digital radio multiplex.

  • Medicinal and agrochemical products can be granted a Supplementary Protection Certificate, an intellectual property right associated with patents, to provide up to five years of additional rights and protections once their patents have expired. In order to apply for an SPC, a product must receive approval to be sold on the UK market. Under the Northern Ireland/Ireland Protocol, products to be sold in Northern Ireland must obtain approval under EU law, whilst products to be sold in the rest of the UK will obtain approval under UK law. Currently, this marketing authorisation is only given on a UK-wide basis. This regulation amends the market authorisation process to enable authorisations to be granted for the Northern Ireland market only and for the Great Britain market only.

  • There is currently a system for mutual recognition of health and social care qualifications within and between European Economic Area states and Switzerland. The UK has passed legislation amending its provisions in this area to take account of its exit from the EU. In recent agreements with Switzerland and the European Free Trade Area states, the UK committed to conditions for these countries which go further than the legislation that has already been passed. The European Qualifications (Health and Social Care Professions) (EFTA States) (Amendment etc.) (EU Exit) Regulations 2020 would implement these commitments.